Antwerp, Belgium and London - 31 July 2014 – genae, a global Contract Research Organization (CRO) and services provider for the medical industries, has incorporated genae UK in London.
"The mature and high value medical device market in Western Europe is wealthy and developed. The friction between attempts to contain health costs and a desire to remain at the forefront of technological innovation leads to an increased demand for efficiencies. For example: medical devices that facilitate minimally invasive therapies to ensure a faster turnaround of patients." said Bart Segers, CEO at genae. "The incorporation of genae UK is a logical step in our commitment to provide high quality research services on a global scale."
The United Kingdom has one of the largest medical device markets in the world. It was valued at USD 8.9 billion in 2012 and it is projected to increase by a CAGR of 6.0% until 2017. Health expenditure was estimated at USD 234 billion in 2012, equal to 9.5% of GDP.
genae associates nv is a privately held company with principal offices in Antwerp, Belgium and is part of the genae group, the medical device CRO.